BackCellebrite DI Overview

Cellebrite DI Total Liabilities

Latest total liabilities for CLBT: $490M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$489.18M
↑ 26.52% YoYΔ $102.55M vs prior year quarter

Peer trimmed avg / median

Loading

Cellebrite DI Total Liabilities History

Loading

Cellebrite DI vs. peers: Total Liabilities Comparison

Loading

Cellebrite DI Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cellebrite DI (CLBT) FAQ

As of the most recent data (September 2026), CLBT shows a total liabilities of $490M. That compares with $390M in the prior-year period — up 26.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CLBT's total liabilities is now $490M (was $390M) — a 26.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cellebrite DI is outperforming or lagging.

Tracking CLBT's total liabilities over time shows whether Cellebrite DI is scaling, shrinking, or reshaping that part of the business. The current reading is $490M That compares with $390M in the prior-year period — up 26.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Cellebrite DI's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $490M) with ownership activity and broader fundamentals.

Cellebrite DI's total liabilities is $490M; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.